[BRIEFING.COM] The stock market was mixed at the index level today, though broader market sentiment was negative throughout the session. At the close, decliners outpaced advancers by a 2-to-1 ratio at the NYSE and a 3-to-2 margin at the Nasdaq.
The underlying negative bias stemmed largely from President-elect Trump's announcement that he plans to impose tariffs—an additional 10% on imports from China and 25% on goods from Mexico and Canada—on his first day in office, contingent upon halting migrant flows and the trafficking of fentanyl into the U.S.
Concerns over inflationary pressures were piqued by these comments, initially sending Treasury yields higher and adding pressure on equities. The 10-yr yield reached 4.32% earlier and the 2-yr yield was at 4.29% despite the sharp 17.3% month-over-month decline in new home sales for October and a notable drop in the November Consumer Confidence Report, which showed a 12-month inflation expectations reading of 4.9%—the lowest since March 2020 (though still elevated, it signals a trend in the right direction).
The bond market shook off its early fears, though, and yields settled below intraday highs. The 10-yr yield settled four basis points higher than yesterday at 4.30% and the 2-yr yield settled two basis points lower at 4.25%. The Treasury market was also reacting to the FOMC Minutes from the November 6-7 meeting, which didn't contain anything surprising, and a $70 billion 5-yr note offering that met solid demand.
Despite the negative skew in market breadth, the equity market also seemed to brush off some its early concerns. The S&P 500 (+0.6%), Nasdaq Composite (+0.6%), and Dow Jones Industrial Average (+0.3%) closed near their best levels of the day. The DJIA and S&P 500 also logged fresh record intraday highs.
The Russell 2000 (-0.7%) and S&P Mid Cap 400 (-0.4%) closed lower, largely driven by profit-taking activity. The former is still 10.4% higher this month and the latter sits on a 9.0% gain.
On an individual basis, Dow component Amgen (AMGN 280.01, -13.99, -4.8%) garnered some negative attention after disappointing news from its Phase 2 trial update for the weight-loss drug MariTide.
Other story stocks included retailers that reported earnings like Best Buy (BBY 88.48, -4.55, -4.9%), Kohl's (KSS 15.22, -3.12, -17.0%), Abercrombie & Fitch (ANF 146.62, -7.88, -5.1%), and Dick's Sporting Goods (DKS 212.22, -3.01, -1.4%).
Reviewing today's economic data:
Looking ahead, Wednesday's calendar features a big batch of economic data due to the market holiday this week. The lineup features: